Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related  | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Acute myeloid leukemia 💬 17 genes, 30 drugs (DrugBank) and 62 diseases  | 
MTOR [1] MTOR 💬Acute myeloid leukemia
  | 
Sirolimus  Sirolimus  💬Acute myeloid leukemia
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬1. Acute myeloid leukemia
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Adipocytokine signaling pathway 💬 16 genes, 31 drugs (DrugBank) and 95 diseases  | 
MTOR [1] MTOR 💬Adipocytokine signaling pathway
  | 
Sirolimus  Sirolimus  💬Adipocytokine signaling pathway
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬2. Adipocytokine signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Adipocytokine signaling pathway 💬 16 genes, 31 drugs (DrugBank) and 95 diseases  | 
TNF [1] TNF 💬Adipocytokine signaling pathway
  | 
Etanercept  Etanercept  💬Adipocytokine signaling pathway
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬3. Adipocytokine signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | African trypanosomiasis 💬 9 genes, 22 drugs (DrugBank) and 59 diseases  | 
TNF [1] TNF 💬African trypanosomiasis
  | 
Etanercept  Etanercept  💬African trypanosomiasis
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬4. African trypanosomiasis
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | AGE-RAGE signaling pathway in diabetic complications 💬 26 genes, 45 drugs (DrugBank) and 83 diseases  | 
TNF [1] TNF 💬AGE-RAGE signaling pathway in diabetic complications
  | 
Etanercept  Etanercept  💬AGE-RAGE signaling pathway in diabetic complications
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬5. AGE-RAGE signaling pathway in diabetic complications
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | Alcoholic liver disease 💬 39 genes, 46 drugs (DrugBank) and 87 diseases  | 
TNF [1] TNF 💬Alcoholic liver disease
  | 
Etanercept  Etanercept  💬Alcoholic liver disease
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬6. Alcoholic liver disease
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | Allograft rejection 💬 11 genes, 23 drugs (DrugBank) and 56 diseases  | 
TNF [1] TNF 💬Allograft rejection
  | 
Etanercept  Etanercept  💬Allograft rejection
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬7. Allograft rejection
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | Alzheimer disease 💬 55 genes, 116 drugs (DrugBank) and 122 diseases  | 
MTOR [1] MTOR 💬Alzheimer disease
  | 
Sirolimus  Sirolimus  💬Alzheimer disease
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬8. Alzheimer disease
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 | Alzheimer disease 💬 55 genes, 116 drugs (DrugBank) and 122 diseases  | 
TNF [1] TNF 💬Alzheimer disease
  | 
Etanercept  Etanercept  💬Alzheimer disease
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬9. Alzheimer disease
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 | Amoebiasis 💬 19 genes, 29 drugs (DrugBank) and 63 diseases  | 
IL1R1 [2] IL1R1, IL1R2 💬
 | 
Anakinra  Anakinra  💬Amoebiasis
  | Anakinra | 002 [18]  2 , 13, 15, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬10. Amoebiasis
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 11 | Amoebiasis 💬 19 genes, 29 drugs (DrugBank) and 63 diseases  | 
TNF [1] TNF 💬Amoebiasis
  | 
Etanercept  Etanercept  💬Amoebiasis
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬11. Amoebiasis
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 12 | AMPK signaling pathway 💬 16 genes, 49 drugs (DrugBank) and 93 diseases  | 
HMGCR [1] HMGCR 💬AMPK signaling pathway
  | 
Simvastatin  Simvastatin  💬AMPK signaling pathway
  | Simvastatin | 006 [21]  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬12. AMPK signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 13 | AMPK signaling pathway 💬 16 genes, 49 drugs (DrugBank) and 93 diseases  | 
MTOR [1] MTOR 💬AMPK signaling pathway
  | 
Sirolimus  Sirolimus  💬AMPK signaling pathway
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬13. AMPK signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 14 | AMPK signaling pathway 💬 16 genes, 49 drugs (DrugBank) and 93 diseases  | 
PPARG [1] PPARG 💬AMPK signaling pathway
  | 
Pioglitazone  Pioglitazone  💬AMPK signaling pathway
  | Pioglitazone | 002 [17]  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬14. AMPK signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15 | Amyotrophic lateral sclerosis 💬 35 genes, 48 drugs (DrugBank) and 108 diseases  | 
MTOR [1] MTOR 💬Amyotrophic lateral sclerosis
  | 
Sirolimus  Sirolimus  💬Amyotrophic lateral sclerosis
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬15. Amyotrophic lateral sclerosis
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 16 | Amyotrophic lateral sclerosis 💬 35 genes, 48 drugs (DrugBank) and 108 diseases  | 
TNF [1] TNF 💬Amyotrophic lateral sclerosis
  | 
Etanercept  Etanercept  💬Amyotrophic lateral sclerosis
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬16. Amyotrophic lateral sclerosis
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 17 | Antifolate resistance 💬 8 genes, 21 drugs (DrugBank) and 66 diseases  | 
TNF [1] TNF 💬Antifolate resistance
  | 
Etanercept  Etanercept  💬Antifolate resistance
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬17. Antifolate resistance
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 18 | Antigen processing and presentation 💬 4 genes, 15 drugs (DrugBank) and 52 diseases  | 
TNF [1] TNF 💬Antigen processing and presentation
  | 
Etanercept  Etanercept  💬Antigen processing and presentation
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬18. Antigen processing and presentation
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 19 | Apelin signaling pathway 💬 12 genes, 30 drugs (DrugBank) and 72 diseases  | 
MTOR [1] MTOR 💬Apelin signaling pathway
  | 
Sirolimus  Sirolimus  💬Apelin signaling pathway
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬19. Apelin signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20 | Apoptosis 💬 16 genes, 28 drugs (DrugBank) and 59 diseases  | 
TNF [1] TNF 💬Apoptosis
  | 
Etanercept  Etanercept  💬Apoptosis
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬20. Apoptosis
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 21 | Arrhythmogenic right ventricular cardiomyopathy 💬 11 genes, 24 drugs (DrugBank) and 28 diseases  | 
ITGA4 [1] ITGA4 💬Arrhythmogenic right ventricular cardiomyopathy
  | 
Natalizumab  Natalizumab  💬Arrhythmogenic right ventricular cardiomyopathy
  | Natalizumab | 013 [6] 13, 15, 25, 46, 63, 96 💬21. Arrhythmogenic right ventricular cardiomyopathy
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 22 | Asthma 💬 8 genes, 22 drugs (DrugBank) and 55 diseases  | 
TNF [1] TNF 💬Asthma
  | 
Etanercept  Etanercept  💬Asthma
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬22. Asthma
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 23 | Autophagy - animal 💬 13 genes, 18 drugs (DrugBank) and 62 diseases  | 
MTOR [1] MTOR 💬Autophagy - animal
  | 
Sirolimus  Sirolimus  💬Autophagy - animal
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬23. Autophagy - animal
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 24 | Autophagy - other 💬 1 gene, 3 drugs (DrugBank) and 41 diseases  | 
MTOR [1] MTOR 💬Autophagy - other
  | 
Sirolimus  Sirolimus  💬Autophagy - other
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬24. Autophagy - other
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 25 | Bile secretion 💬 11 genes, 29 drugs (DrugBank) and 60 diseases  | 
HMGCR [1] HMGCR 💬Bile secretion
  | 
Simvastatin  Simvastatin  💬Bile secretion
  | Simvastatin | 006 [21]  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬25. Bile secretion
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 26 | Breast cancer 💬 21 genes, 60 drugs (DrugBank) and 74 diseases  | 
MTOR [1] MTOR 💬Breast cancer
  | 
Sirolimus  Sirolimus  💬Breast cancer
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬26. Breast cancer
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 27 | C-type lectin receptor signaling pathway 💬 26 genes, 64 drugs (DrugBank) and 99 diseases  | 
TNF [1] TNF 💬C-type lectin receptor signaling pathway
  | 
Etanercept  Etanercept  💬C-type lectin receptor signaling pathway
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬27. C-type lectin receptor signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 28 | Cell adhesion molecules 💬 14 genes, 22 drugs (DrugBank) and 35 diseases  | 
ITGA4 [1] ITGA4 💬Cell adhesion molecules
  | 
Natalizumab  Natalizumab  💬Cell adhesion molecules
  | Natalizumab | 013 [6] 13, 15, 25, 46, 63, 96 💬28. Cell adhesion molecules
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 29 | Cellular senescence 💬 26 genes, 40 drugs (DrugBank) and 92 diseases  | 
MTOR [1] MTOR 💬Cellular senescence
  | 
Sirolimus  Sirolimus  💬Cellular senescence
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬29. Cellular senescence
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 30 | Central carbon metabolism in cancer 💬 18 genes, 29 drugs (DrugBank) and 56 diseases  | 
MTOR [1] MTOR 💬Central carbon metabolism in cancer
  | 
Sirolimus  Sirolimus  💬Central carbon metabolism in cancer
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬30. Central carbon metabolism in cancer
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 31 | Chagas disease 💬 28 genes, 44 drugs (DrugBank) and 77 diseases  | 
TNF [1] TNF 💬Chagas disease
  | 
Etanercept  Etanercept  💬Chagas disease
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬31. Chagas disease
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 32 | Chemical carcinogenesis - receptor activation 💬 39 genes, 126 drugs (DrugBank) and 116 diseases  | 
MTOR [1] MTOR 💬Chemical carcinogenesis - receptor activation
  | 
Sirolimus  Sirolimus  💬Chemical carcinogenesis - receptor activation
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬32. Chemical carcinogenesis - receptor activation
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 33 | Choline metabolism in cancer 💬 11 genes, 25 drugs (DrugBank) and 53 diseases  | 
MTOR [1] MTOR 💬Choline metabolism in cancer
  | 
Sirolimus  Sirolimus  💬Choline metabolism in cancer
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬33. Choline metabolism in cancer
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 34 | Colorectal cancer 💬 14 genes, 23 drugs (DrugBank) and 49 diseases  | 
MTOR [1] MTOR 💬Colorectal cancer
  | 
Sirolimus  Sirolimus  💬Colorectal cancer
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬34. Colorectal cancer
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 35 | Coronavirus disease - COVID-19 💬 51 genes, 94 drugs (DrugBank) and 91 diseases  | 
TNF [1] TNF 💬Coronavirus disease - COVID-19
  | 
Etanercept  Etanercept  💬Coronavirus disease - COVID-19
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬35. Coronavirus disease - COVID-19
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 36 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases  | 
ACVR2A [2] ACVR2A, ACVR2B 💬
 | 
Bimagrumab  Bimagrumab  💬Cytokine-cytokine receptor interaction
  | Bimagrumab | 015 [1] 15 💬36. Cytokine-cytokine receptor interaction
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 37 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases  | 
IL1R1 [2] IL1R1, IL1R2 💬
 | 
Anakinra  Anakinra  💬Cytokine-cytokine receptor interaction
  | Anakinra | 002 [18]  2 , 13, 15, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬37. Cytokine-cytokine receptor interaction
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 38 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases  | 
LTA [2] LTA, TNF 💬
 | 
Etanercept  Etanercept  💬Cytokine-cytokine receptor interaction
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬38. Cytokine-cytokine receptor interaction
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 39 | Diabetic cardiomyopathy 💬 26 genes, 42 drugs (DrugBank) and 73 diseases  | 
MTOR [1] MTOR 💬Diabetic cardiomyopathy
  | 
Sirolimus  Sirolimus  💬Diabetic cardiomyopathy
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬39. Diabetic cardiomyopathy
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 40 | Dilated cardiomyopathy 💬 17 genes, 55 drugs (DrugBank) and 83 diseases  | 
ITGA4 [1] ITGA4 💬Dilated cardiomyopathy
  | 
Natalizumab  Natalizumab  💬Dilated cardiomyopathy
  | Natalizumab | 013 [6] 13, 15, 25, 46, 63, 96 💬40. Dilated cardiomyopathy
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 41 | Dilated cardiomyopathy 💬 17 genes, 55 drugs (DrugBank) and 83 diseases  | 
TNF [1] TNF 💬Dilated cardiomyopathy
  | 
Etanercept  Etanercept  💬Dilated cardiomyopathy
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬41. Dilated cardiomyopathy
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 42 | ECM-receptor interaction 💬 6 genes, 9 drugs (DrugBank) and 15 diseases  | 
ITGA4 [1] ITGA4 💬ECM-receptor interaction
  | 
Natalizumab  Natalizumab  💬ECM-receptor interaction
  | Natalizumab | 013 [6] 13, 15, 25, 46, 63, 96 💬42. ECM-receptor interaction
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 43 | EGFR tyrosine kinase inhibitor resistance 💬 26 genes, 56 drugs (DrugBank) and 83 diseases  | 
MTOR [1] MTOR 💬EGFR tyrosine kinase inhibitor resistance
  | 
Sirolimus  Sirolimus  💬EGFR tyrosine kinase inhibitor resistance
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬43. EGFR tyrosine kinase inhibitor resistance
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 44 | Endocrine resistance 💬 20 genes, 43 drugs (DrugBank) and 62 diseases  | 
MTOR [1] MTOR 💬Endocrine resistance
  | 
Sirolimus  Sirolimus  💬Endocrine resistance
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬44. Endocrine resistance
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 45 | Epstein-Barr virus infection 💬 44 genes, 62 drugs (DrugBank) and 66 diseases  | 
TNF [1] TNF 💬Epstein-Barr virus infection
  | 
Etanercept  Etanercept  💬Epstein-Barr virus infection
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬45. Epstein-Barr virus infection
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 46 | ErbB signaling pathway 💬 14 genes, 26 drugs (DrugBank) and 53 diseases  | 
MTOR [1] MTOR 💬ErbB signaling pathway
  | 
Sirolimus  Sirolimus  💬ErbB signaling pathway
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬46. ErbB signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 47 | Fc epsilon RI signaling pathway 💬 20 genes, 42 drugs (DrugBank) and 62 diseases  | 
TNF [1] TNF 💬Fc epsilon RI signaling pathway
  | 
Etanercept  Etanercept  💬Fc epsilon RI signaling pathway
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬47. Fc epsilon RI signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 48 | Fluid shear stress and atherosclerosis 💬 29 genes, 48 drugs (DrugBank) and 86 diseases  | 
ACVR2A [2] ACVR2A, ACVR2B 💬
 | 
Bimagrumab  Bimagrumab  💬Fluid shear stress and atherosclerosis
  | Bimagrumab | 015 [1] 15 💬48. Fluid shear stress and atherosclerosis
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 49 | Fluid shear stress and atherosclerosis 💬 29 genes, 48 drugs (DrugBank) and 86 diseases  | 
IL1R1 [2] IL1R1, IL1R2 💬
 | 
Anakinra  Anakinra  💬Fluid shear stress and atherosclerosis
  | Anakinra | 002 [18]  2 , 13, 15, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬49. Fluid shear stress and atherosclerosis
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 50 | Fluid shear stress and atherosclerosis 💬 29 genes, 48 drugs (DrugBank) and 86 diseases  | 
TNF [1] TNF 💬Fluid shear stress and atherosclerosis
  | 
Etanercept  Etanercept  💬Fluid shear stress and atherosclerosis
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬50. Fluid shear stress and atherosclerosis
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 51 | Focal adhesion 💬 27 genes, 43 drugs (DrugBank) and 44 diseases  | 
ITGA4 [1] ITGA4 💬Focal adhesion
  | 
Natalizumab  Natalizumab  💬Focal adhesion
  | Natalizumab | 013 [6] 13, 15, 25, 46, 63, 96 💬51. Focal adhesion
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 52 | Gastric cancer 💬 21 genes, 34 drugs (DrugBank) and 57 diseases  | 
MTOR [1] MTOR 💬Gastric cancer
  | 
Sirolimus  Sirolimus  💬Gastric cancer
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬52. Gastric cancer
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 53 | Glioma 💬 15 genes, 30 drugs (DrugBank) and 57 diseases  | 
MTOR [1] MTOR 💬Glioma
  | 
Sirolimus  Sirolimus  💬Glioma
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬53. Glioma
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 54 | Graft-versus-host disease 💬 7 genes, 22 drugs (DrugBank) and 60 diseases  | 
TNF [1] TNF 💬Graft-versus-host disease
  | 
Etanercept  Etanercept  💬Graft-versus-host disease
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬54. Graft-versus-host disease
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 55 | Growth hormone synthesis, secretion and action 💬 24 genes, 41 drugs (DrugBank) and 76 diseases  | 
MTOR [1] MTOR 💬Growth hormone synthesis, secretion and action
  | 
Sirolimus  Sirolimus  💬Growth hormone synthesis, secretion and action
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬55. Growth hormone synthesis, secretion and action
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 56 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases  | 
IL1R1 [2] IL1R1, IL1R2 💬
 | 
Anakinra  Anakinra  💬Hematopoietic cell lineage
  | Anakinra | 002 [18]  2 , 13, 15, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬56. Hematopoietic cell lineage
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 57 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases  | 
ITGA4 [1] ITGA4 💬Hematopoietic cell lineage
  | 
Natalizumab  Natalizumab  💬Hematopoietic cell lineage
  | Natalizumab | 013 [6] 13, 15, 25, 46, 63, 96 💬57. Hematopoietic cell lineage
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 58 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases  | 
TNF [1] TNF 💬Hematopoietic cell lineage
  | 
Etanercept  Etanercept  💬Hematopoietic cell lineage
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬58. Hematopoietic cell lineage
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 59 | Hepatitis B 💬 41 genes, 54 drugs (DrugBank) and 73 diseases  | 
TNF [1] TNF 💬Hepatitis B
  | 
Etanercept  Etanercept  💬Hepatitis B
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬59. Hepatitis B
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 60 | Hepatitis C 💬 34 genes, 59 drugs (DrugBank) and 72 diseases  | 
TNF [1] TNF 💬Hepatitis C
  | 
Etanercept  Etanercept  💬Hepatitis C
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬60. Hepatitis C
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 61 | Hepatocellular carcinoma 💬 21 genes, 31 drugs (DrugBank) and 57 diseases  | 
MTOR [1] MTOR 💬Hepatocellular carcinoma
  | 
Sirolimus  Sirolimus  💬Hepatocellular carcinoma
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬61. Hepatocellular carcinoma
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 62 | Herpes simplex virus 1 infection 💬 43 genes, 65 drugs (DrugBank) and 94 diseases  | 
LTA [2] LTA, TNF 💬
 | 
Etanercept  Etanercept  💬Herpes simplex virus 1 infection
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬62. Herpes simplex virus 1 infection
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 63 | Herpes simplex virus 1 infection 💬 43 genes, 65 drugs (DrugBank) and 94 diseases  | 
MTOR [1] MTOR 💬Herpes simplex virus 1 infection
  | 
Sirolimus  Sirolimus  💬Herpes simplex virus 1 infection
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬63. Herpes simplex virus 1 infection
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 64 | HIF-1 signaling pathway 💬 23 genes, 48 drugs (DrugBank) and 76 diseases  | 
MTOR [1] MTOR 💬HIF-1 signaling pathway
  | 
Sirolimus  Sirolimus  💬HIF-1 signaling pathway
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬64. HIF-1 signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 65 | Human cytomegalovirus infection 💬 56 genes, 104 drugs (DrugBank) and 120 diseases  | 
IL1R1 [1] IL1R1 💬Human cytomegalovirus infection
  | 
Anakinra  Anakinra  💬Human cytomegalovirus infection
  | Anakinra | 002 [18]  2 , 13, 15, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬65. Human cytomegalovirus infection
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 66 | Human cytomegalovirus infection 💬 56 genes, 104 drugs (DrugBank) and 120 diseases  | 
MTOR [1] MTOR 💬Human cytomegalovirus infection
  | 
Sirolimus  Sirolimus  💬Human cytomegalovirus infection
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬66. Human cytomegalovirus infection
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 67 | Human cytomegalovirus infection 💬 56 genes, 104 drugs (DrugBank) and 120 diseases  | 
TNF [1] TNF 💬Human cytomegalovirus infection
  | 
Etanercept  Etanercept  💬Human cytomegalovirus infection
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬67. Human cytomegalovirus infection
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 68 | Human immunodeficiency virus 1 infection 💬 41 genes, 43 drugs (DrugBank) and 89 diseases  | 
MTOR [1] MTOR 💬Human immunodeficiency virus 1 infection
  | 
Sirolimus  Sirolimus  💬Human immunodeficiency virus 1 infection
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬68. Human immunodeficiency virus 1 infection
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 69 | Human immunodeficiency virus 1 infection 💬 41 genes, 43 drugs (DrugBank) and 89 diseases  | 
TNF [1] TNF 💬Human immunodeficiency virus 1 infection
  | 
Etanercept  Etanercept  💬Human immunodeficiency virus 1 infection
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬69. Human immunodeficiency virus 1 infection
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 70 | Human papillomavirus infection 💬 40 genes, 91 drugs (DrugBank) and 105 diseases  | 
ITGA4 [1] ITGA4 💬Human papillomavirus infection
  | 
Natalizumab  Natalizumab  💬Human papillomavirus infection
  | Natalizumab | 013 [6] 13, 15, 25, 46, 63, 96 💬70. Human papillomavirus infection
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 71 | Human papillomavirus infection 💬 40 genes, 91 drugs (DrugBank) and 105 diseases  | 
MTOR [1] MTOR 💬Human papillomavirus infection
  | 
Sirolimus  Sirolimus  💬Human papillomavirus infection
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬71. Human papillomavirus infection
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 72 | Human papillomavirus infection 💬 40 genes, 91 drugs (DrugBank) and 105 diseases  | 
TNF [1] TNF 💬Human papillomavirus infection
  | 
Etanercept  Etanercept  💬Human papillomavirus infection
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬72. Human papillomavirus infection
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 73 | Human T-cell leukemia virus 1 infection 💬 37 genes, 59 drugs (DrugBank) and 84 diseases  | 
IL1R1 [2] IL1R1, IL1R2 💬
 | 
Anakinra  Anakinra  💬Human T-cell leukemia virus 1 infection
  | Anakinra | 002 [18]  2 , 13, 15, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬73. Human T-cell leukemia virus 1 infection
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 74 | Human T-cell leukemia virus 1 infection 💬 37 genes, 59 drugs (DrugBank) and 84 diseases  | 
LTA [2] LTA, TNF 💬
 | 
Etanercept  Etanercept  💬Human T-cell leukemia virus 1 infection
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬74. Human T-cell leukemia virus 1 infection
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 75 | Huntington disease 💬 24 genes, 33 drugs (DrugBank) and 82 diseases  | 
MTOR [1] MTOR 💬Huntington disease
  | 
Sirolimus  Sirolimus  💬Huntington disease
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬75. Huntington disease
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 76 | Huntington disease 💬 24 genes, 33 drugs (DrugBank) and 82 diseases  | 
PPARG [1] PPARG 💬Huntington disease
  | 
Pioglitazone  Pioglitazone  💬Huntington disease
  | Pioglitazone | 002 [17]  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬76. Huntington disease
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 77 | Hypertrophic cardiomyopathy 💬 20 genes, 51 drugs (DrugBank) and 87 diseases  | 
ITGA4 [1] ITGA4 💬Hypertrophic cardiomyopathy
  | 
Natalizumab  Natalizumab  💬Hypertrophic cardiomyopathy
  | Natalizumab | 013 [6] 13, 15, 25, 46, 63, 96 💬77. Hypertrophic cardiomyopathy
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 78 | Hypertrophic cardiomyopathy 💬 20 genes, 51 drugs (DrugBank) and 87 diseases  | 
TNF [1] TNF 💬Hypertrophic cardiomyopathy
  | 
Etanercept  Etanercept  💬Hypertrophic cardiomyopathy
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬78. Hypertrophic cardiomyopathy
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 79 | IL-17 signaling pathway 💬 20 genes, 60 drugs (DrugBank) and 83 diseases  | 
TNF [1] TNF 💬IL-17 signaling pathway
  | 
Etanercept  Etanercept  💬IL-17 signaling pathway
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬79. IL-17 signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 80 | Inflammatory bowel disease 💬 24 genes, 43 drugs (DrugBank) and 64 diseases  | 
TNF [1] TNF 💬Inflammatory bowel disease
  | 
Etanercept  Etanercept  💬Inflammatory bowel disease
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬80. Inflammatory bowel disease
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 81 | Inflammatory mediator regulation of TRP channels 💬 23 genes, 43 drugs (DrugBank) and 59 diseases  | 
IL1R1 [1] IL1R1 💬Inflammatory mediator regulation of TRP channels
  | 
Anakinra  Anakinra  💬Inflammatory mediator regulation of TRP channels
  | Anakinra | 002 [18]  2 , 13, 15, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬81. Inflammatory mediator regulation of TRP channels
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 82 | Influenza A 💬 45 genes, 63 drugs (DrugBank) and 85 diseases  | 
TNF [1] TNF 💬Influenza A
  | 
Etanercept  Etanercept  💬Influenza A
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬82. Influenza A
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 83 | Insulin resistance 💬 18 genes, 33 drugs (DrugBank) and 95 diseases  | 
MTOR [1] MTOR 💬Insulin resistance
  | 
Sirolimus  Sirolimus  💬Insulin resistance
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬83. Insulin resistance
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 84 | Insulin resistance 💬 18 genes, 33 drugs (DrugBank) and 95 diseases  | 
TNF [1] TNF 💬Insulin resistance
  | 
Etanercept  Etanercept  💬Insulin resistance
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬84. Insulin resistance
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 85 | Insulin secretion 💬 14 genes, 39 drugs (DrugBank) and 44 diseases  | 
SNAP25 [1] SNAP25 💬Insulin secretion
  | 
Botulinum toxin type A  Botulinum toxin type A  💬Insulin secretion
  | Botulinum toxin type A | 002 [14]  2 ,  5 ,  6 ,  7 , 13, 15, 17, 36, 47, 51, 70, 113, 149, 226 💬85. Insulin secretion
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 86 | Insulin signaling pathway 💬 12 genes, 26 drugs (DrugBank) and 66 diseases  | 
MTOR [1] MTOR 💬Insulin signaling pathway
  | 
Sirolimus  Sirolimus  💬Insulin signaling pathway
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬86. Insulin signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 87 | Intestinal immune network for IgA production 💬 16 genes, 27 drugs (DrugBank) and 47 diseases  | 
ITGA4 [1] ITGA4 💬Intestinal immune network for IgA production
  | 
Natalizumab  Natalizumab  💬Intestinal immune network for IgA production
  | Natalizumab | 013 [6] 13, 15, 25, 46, 63, 96 💬87. Intestinal immune network for IgA production
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 88 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases  | 
MTOR [1] MTOR 💬JAK-STAT signaling pathway
  | 
Sirolimus  Sirolimus  💬JAK-STAT signaling pathway
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬88. JAK-STAT signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 89 | Kaposi sarcoma-associated herpesvirus infection 💬 50 genes, 84 drugs (DrugBank) and 108 diseases  | 
MTOR [1] MTOR 💬Kaposi sarcoma-associated herpesvirus infection
  | 
Sirolimus  Sirolimus  💬Kaposi sarcoma-associated herpesvirus infection
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬89. Kaposi sarcoma-associated herpesvirus infection
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 90 | Legionellosis 💬 9 genes, 22 drugs (DrugBank) and 61 diseases  | 
TNF [1] TNF 💬Legionellosis
  | 
Etanercept  Etanercept  💬Legionellosis
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬90. Legionellosis
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 91 | Leishmaniasis 💬 25 genes, 63 drugs (DrugBank) and 93 diseases  | 
ITGA4 [1] ITGA4 💬Leishmaniasis
  | 
Natalizumab  Natalizumab  💬Leishmaniasis
  | Natalizumab | 013 [6] 13, 15, 25, 46, 63, 96 💬91. Leishmaniasis
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 92 | Leishmaniasis 💬 25 genes, 63 drugs (DrugBank) and 93 diseases  | 
TNF [1] TNF 💬Leishmaniasis
  | 
Etanercept  Etanercept  💬Leishmaniasis
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬92. Leishmaniasis
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 93 | Leukocyte transendothelial migration 💬 13 genes, 14 drugs (DrugBank) and 30 diseases  | 
ITGA4 [1] ITGA4 💬Leukocyte transendothelial migration
  | 
Natalizumab  Natalizumab  💬Leukocyte transendothelial migration
  | Natalizumab | 013 [6] 13, 15, 25, 46, 63, 96 💬93. Leukocyte transendothelial migration
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 94 | Lipid and atherosclerosis 💬 46 genes, 56 drugs (DrugBank) and 93 diseases  | 
PPARG [1] PPARG 💬Lipid and atherosclerosis
  | 
Pioglitazone  Pioglitazone  💬Lipid and atherosclerosis
  | Pioglitazone | 002 [17]  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬94. Lipid and atherosclerosis
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 95 | Lipid and atherosclerosis 💬 46 genes, 56 drugs (DrugBank) and 93 diseases  | 
TNF [1] TNF 💬Lipid and atherosclerosis
  | 
Etanercept  Etanercept  💬Lipid and atherosclerosis
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬95. Lipid and atherosclerosis
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 96 | Longevity regulating pathway 💬 11 genes, 20 drugs (DrugBank) and 68 diseases  | 
MTOR [1] MTOR 💬Longevity regulating pathway
  | 
Sirolimus  Sirolimus  💬Longevity regulating pathway
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬96. Longevity regulating pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 97 | Longevity regulating pathway 💬 11 genes, 20 drugs (DrugBank) and 68 diseases  | 
PPARG [1] PPARG 💬Longevity regulating pathway
  | 
Pioglitazone  Pioglitazone  💬Longevity regulating pathway
  | Pioglitazone | 002 [17]  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬97. Longevity regulating pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 98 | Longevity regulating pathway - multiple species 💬 11 genes, 15 drugs (DrugBank) and 62 diseases  | 
MTOR [1] MTOR 💬Longevity regulating pathway - multiple species
  | 
Sirolimus  Sirolimus  💬Longevity regulating pathway - multiple species
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬98. Longevity regulating pathway - multiple species
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 99 | Malaria 💬 15 genes, 28 drugs (DrugBank) and 61 diseases  | 
TNF [1] TNF 💬Malaria
  | 
Etanercept  Etanercept  💬Malaria
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬99. Malaria
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 100 | MAPK signaling pathway 💬 61 genes, 85 drugs (DrugBank) and 110 diseases  | 
IL1R1 [1] IL1R1 💬MAPK signaling pathway
  | 
Anakinra  Anakinra  💬MAPK signaling pathway
  | Anakinra | 002 [18]  2 , 13, 15, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬100. MAPK signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 101 | MAPK signaling pathway 💬 61 genes, 85 drugs (DrugBank) and 110 diseases  | 
TNF [1] TNF 💬MAPK signaling pathway
  | 
Etanercept  Etanercept  💬MAPK signaling pathway
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬101. MAPK signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 102 | Metabolic pathways 💬 111 genes, 155 drugs (DrugBank) and 137 diseases  | 
HMGCR [1] HMGCR 💬Metabolic pathways
  | 
Simvastatin  Simvastatin  💬Metabolic pathways
  | Simvastatin | 006 [21]  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬102. Metabolic pathways
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 103 | MicroRNAs in cancer 💬 31 genes, 65 drugs (DrugBank) and 85 diseases  | 
MTOR [1] MTOR 💬MicroRNAs in cancer
  | 
Sirolimus  Sirolimus  💬MicroRNAs in cancer
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬103. MicroRNAs in cancer
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 104 | mTOR signaling pathway 💬 14 genes, 32 drugs (DrugBank) and 91 diseases  | 
MTOR [1] MTOR 💬mTOR signaling pathway
  | 
Sirolimus  Sirolimus  💬mTOR signaling pathway
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬104. mTOR signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 105 | mTOR signaling pathway 💬 14 genes, 32 drugs (DrugBank) and 91 diseases  | 
TNF [1] TNF 💬mTOR signaling pathway
  | 
Etanercept  Etanercept  💬mTOR signaling pathway
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬105. mTOR signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 106 | Natural killer cell mediated cytotoxicity 💬 37 genes, 42 drugs (DrugBank) and 80 diseases  | 
TNF [1] TNF 💬Natural killer cell mediated cytotoxicity
  | 
Etanercept  Etanercept  💬Natural killer cell mediated cytotoxicity
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬106. Natural killer cell mediated cytotoxicity
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 107 | Necroptosis 💬 28 genes, 39 drugs (DrugBank) and 68 diseases  | 
TNF [1] TNF 💬Necroptosis
  | 
Etanercept  Etanercept  💬Necroptosis
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬107. Necroptosis
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 108 | Neutrophil extracellular trap formation 💬 35 genes, 36 drugs (DrugBank) and 61 diseases  | 
MTOR [1] MTOR 💬Neutrophil extracellular trap formation
  | 
Sirolimus  Sirolimus  💬Neutrophil extracellular trap formation
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬108. Neutrophil extracellular trap formation
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 109 | NF-kappa B signaling pathway 💬 20 genes, 67 drugs (DrugBank) and 87 diseases  | 
IL1R1 [1] IL1R1 💬NF-kappa B signaling pathway
  | 
Anakinra  Anakinra  💬NF-kappa B signaling pathway
  | Anakinra | 002 [18]  2 , 13, 15, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬109. NF-kappa B signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 110 | NF-kappa B signaling pathway 💬 20 genes, 67 drugs (DrugBank) and 87 diseases  | 
LTA [2] LTA, TNF 💬
 | 
Etanercept  Etanercept  💬NF-kappa B signaling pathway
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬110. NF-kappa B signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 111 | NOD-like receptor signaling pathway 💬 30 genes, 42 drugs (DrugBank) and 65 diseases  | 
TNF [1] TNF 💬NOD-like receptor signaling pathway
  | 
Etanercept  Etanercept  💬NOD-like receptor signaling pathway
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬111. NOD-like receptor signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 112 | Non-alcoholic fatty liver disease 💬 23 genes, 47 drugs (DrugBank) and 86 diseases  | 
PPARG [1] PPARG 💬Non-alcoholic fatty liver disease
  | 
Pioglitazone  Pioglitazone  💬Non-alcoholic fatty liver disease
  | Pioglitazone | 002 [17]  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬112. Non-alcoholic fatty liver disease
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 113 | Non-alcoholic fatty liver disease 💬 23 genes, 47 drugs (DrugBank) and 86 diseases  | 
TNF [1] TNF 💬Non-alcoholic fatty liver disease
  | 
Etanercept  Etanercept  💬Non-alcoholic fatty liver disease
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬113. Non-alcoholic fatty liver disease
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 114 | Osteoclast differentiation 💬 36 genes, 71 drugs (DrugBank) and 93 diseases  | 
IL1R1 [1] IL1R1 💬Osteoclast differentiation
  | 
Anakinra  Anakinra  💬Osteoclast differentiation
  | Anakinra | 002 [18]  2 , 13, 15, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬114. Osteoclast differentiation
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 115 | Osteoclast differentiation 💬 36 genes, 71 drugs (DrugBank) and 93 diseases  | 
PPARG [1] PPARG 💬Osteoclast differentiation
  | 
Pioglitazone  Pioglitazone  💬Osteoclast differentiation
  | Pioglitazone | 002 [17]  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬115. Osteoclast differentiation
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 116 | Osteoclast differentiation 💬 36 genes, 71 drugs (DrugBank) and 93 diseases  | 
TNF [1] TNF 💬Osteoclast differentiation
  | 
Etanercept  Etanercept  💬Osteoclast differentiation
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬116. Osteoclast differentiation
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 117 | Pancreatic cancer 💬 19 genes, 36 drugs (DrugBank) and 67 diseases  | 
MTOR [1] MTOR 💬Pancreatic cancer
  | 
Sirolimus  Sirolimus  💬Pancreatic cancer
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬117. Pancreatic cancer
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 118 | Pathogenic Escherichia coli infection 💬 26 genes, 39 drugs (DrugBank) and 74 diseases  | 
IL1R1 [1] IL1R1 💬Pathogenic Escherichia coli infection
  | 
Anakinra  Anakinra  💬Pathogenic Escherichia coli infection
  | Anakinra | 002 [18]  2 , 13, 15, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬118. Pathogenic Escherichia coli infection
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 119 | Pathogenic Escherichia coli infection 💬 26 genes, 39 drugs (DrugBank) and 74 diseases  | 
TNF [1] TNF 💬Pathogenic Escherichia coli infection
  | 
Etanercept  Etanercept  💬Pathogenic Escherichia coli infection
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬119. Pathogenic Escherichia coli infection
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 120 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases  | 
MTOR [1] MTOR 💬Pathways in cancer
  | 
Sirolimus  Sirolimus  💬Pathways in cancer
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬120. Pathways in cancer
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 121 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases  | 
PPARG [1] PPARG 💬Pathways in cancer
  | 
Pioglitazone  Pioglitazone  💬Pathways in cancer
  | Pioglitazone | 002 [17]  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬121. Pathways in cancer
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 122 | Pathways of neurodegeneration - multiple diseases 💬 59 genes, 120 drugs (DrugBank) and 125 diseases  | 
MTOR [1] MTOR 💬Pathways of neurodegeneration - multiple diseases
  | 
Sirolimus  Sirolimus  💬Pathways of neurodegeneration - multiple diseases
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬122. Pathways of neurodegeneration - multiple diseases
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 123 | Pathways of neurodegeneration - multiple diseases 💬 59 genes, 120 drugs (DrugBank) and 125 diseases  | 
TNF [1] TNF 💬Pathways of neurodegeneration - multiple diseases
  | 
Etanercept  Etanercept  💬Pathways of neurodegeneration - multiple diseases
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬123. Pathways of neurodegeneration - multiple diseases
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 124 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 34 genes, 51 drugs (DrugBank) and 92 diseases  | 
MTOR [1] MTOR 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
  | 
Sirolimus  Sirolimus  💬PD-L1 expression and PD-1 checkpoint pathway in cancer
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬124. PD-L1 expression and PD-1 checkpoint pathway in cancer
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 125 | Pertussis 💬 18 genes, 38 drugs (DrugBank) and 66 diseases  | 
TNF [1] TNF 💬Pertussis
  | 
Etanercept  Etanercept  💬Pertussis
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬125. Pertussis
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 126 | Phospholipase D signaling pathway 💬 23 genes, 51 drugs (DrugBank) and 76 diseases  | 
MTOR [1] MTOR 💬Phospholipase D signaling pathway
  | 
Sirolimus  Sirolimus  💬Phospholipase D signaling pathway
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬126. Phospholipase D signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 127 | PI3K-Akt signaling pathway 💬 76 genes, 112 drugs (DrugBank) and 112 diseases  | 
ITGA4 [1] ITGA4 💬PI3K-Akt signaling pathway
  | 
Natalizumab  Natalizumab  💬PI3K-Akt signaling pathway
  | Natalizumab | 013 [6] 13, 15, 25, 46, 63, 96 💬127. PI3K-Akt signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 128 | PI3K-Akt signaling pathway 💬 76 genes, 112 drugs (DrugBank) and 112 diseases  | 
MTOR [1] MTOR 💬PI3K-Akt signaling pathway
  | 
Sirolimus  Sirolimus  💬PI3K-Akt signaling pathway
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬128. PI3K-Akt signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 129 | PPAR signaling pathway 💬 10 genes, 14 drugs (DrugBank) and 32 diseases  | 
PPARG [1] PPARG 💬PPAR signaling pathway
  | 
Pioglitazone  Pioglitazone  💬PPAR signaling pathway
  | Pioglitazone | 002 [17]  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬129. PPAR signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 130 | Prion disease 💬 41 genes, 66 drugs (DrugBank) and 107 diseases  | 
TNF [1] TNF 💬Prion disease
  | 
Etanercept  Etanercept  💬Prion disease
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬130. Prion disease
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 131 | Prostate cancer 💬 22 genes, 51 drugs (DrugBank) and 80 diseases  | 
IL1R2 [1] IL1R2 💬Prostate cancer
  | 
Anakinra  Anakinra  💬Prostate cancer
  | Anakinra | 002 [18]  2 , 13, 15, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬131. Prostate cancer
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 132 | Prostate cancer 💬 22 genes, 51 drugs (DrugBank) and 80 diseases  | 
MTOR [1] MTOR 💬Prostate cancer
  | 
Sirolimus  Sirolimus  💬Prostate cancer
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬132. Prostate cancer
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 133 | Proteoglycans in cancer 💬 30 genes, 68 drugs (DrugBank) and 96 diseases  | 
MTOR [1] MTOR 💬Proteoglycans in cancer
  | 
Sirolimus  Sirolimus  💬Proteoglycans in cancer
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬133. Proteoglycans in cancer
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 134 | Proteoglycans in cancer 💬 30 genes, 68 drugs (DrugBank) and 96 diseases  | 
TNF [1] TNF 💬Proteoglycans in cancer
  | 
Etanercept  Etanercept  💬Proteoglycans in cancer
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬134. Proteoglycans in cancer
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 135 | Regulation of actin cytoskeleton 💬 28 genes, 60 drugs (DrugBank) and 63 diseases  | 
ITGA4 [1] ITGA4 💬Regulation of actin cytoskeleton
  | 
Natalizumab  Natalizumab  💬Regulation of actin cytoskeleton
  | Natalizumab | 013 [6] 13, 15, 25, 46, 63, 96 💬135. Regulation of actin cytoskeleton
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 136 | Rheumatoid arthritis 💬 22 genes, 49 drugs (DrugBank) and 74 diseases  | 
TNF [1] TNF 💬Rheumatoid arthritis
  | 
Etanercept  Etanercept  💬Rheumatoid arthritis
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬136. Rheumatoid arthritis
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 137 | RIG-I-like receptor signaling pathway 💬 22 genes, 18 drugs (DrugBank) and 55 diseases  | 
TNF [1] TNF 💬RIG-I-like receptor signaling pathway
  | 
Etanercept  Etanercept  💬RIG-I-like receptor signaling pathway
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬137. RIG-I-like receptor signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 138 | Salmonella infection 💬 27 genes, 40 drugs (DrugBank) and 66 diseases  | 
TNF [1] TNF 💬Salmonella infection
  | 
Etanercept  Etanercept  💬Salmonella infection
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬138. Salmonella infection
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 139 | Shigellosis 💬 23 genes, 41 drugs (DrugBank) and 86 diseases  | 
IL1R1 [1] IL1R1 💬Shigellosis
  | 
Anakinra  Anakinra  💬Shigellosis
  | Anakinra | 002 [18]  2 , 13, 15, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬139. Shigellosis
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 140 | Shigellosis 💬 23 genes, 41 drugs (DrugBank) and 86 diseases  | 
MTOR [1] MTOR 💬Shigellosis
  | 
Sirolimus  Sirolimus  💬Shigellosis
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬140. Shigellosis
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 141 | Shigellosis 💬 23 genes, 41 drugs (DrugBank) and 86 diseases  | 
TNF [1] TNF 💬Shigellosis
  | 
Etanercept  Etanercept  💬Shigellosis
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬141. Shigellosis
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 142 | Signaling pathways regulating pluripotency of stem cells 💬 19 genes, 28 drugs (DrugBank) and 48 diseases  | 
ACVR2A [2] ACVR2A, ACVR2B 💬
 | 
Bimagrumab  Bimagrumab  💬Signaling pathways regulating pluripotency of stem cells
  | Bimagrumab | 015 [1] 15 💬142. Signaling pathways regulating pluripotency of stem cells
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 143 | Sphingolipid signaling pathway 💬 30 genes, 52 drugs (DrugBank) and 73 diseases  | 
TNF [1] TNF 💬Sphingolipid signaling pathway
  | 
Etanercept  Etanercept  💬Sphingolipid signaling pathway
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬143. Sphingolipid signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 144 | Spinocerebellar ataxia 💬 17 genes, 25 drugs (DrugBank) and 70 diseases  | 
MTOR [1] MTOR 💬Spinocerebellar ataxia
  | 
Sirolimus  Sirolimus  💬Spinocerebellar ataxia
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬144. Spinocerebellar ataxia
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 145 | Synaptic vesicle cycle 💬 7 genes, 30 drugs (DrugBank) and 40 diseases  | 
SNAP25 [1] SNAP25 💬Synaptic vesicle cycle
  | 
Botulinum toxin type A  Botulinum toxin type A  💬Synaptic vesicle cycle
  | Botulinum toxin type A | 002 [14]  2 ,  5 ,  6 ,  7 , 13, 15, 17, 36, 47, 51, 70, 113, 149, 226 💬145. Synaptic vesicle cycle
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 146 | Systemic lupus erythematosus 💬 14 genes, 38 drugs (DrugBank) and 78 diseases  | 
TNF [1] TNF 💬Systemic lupus erythematosus
  | 
Etanercept  Etanercept  💬Systemic lupus erythematosus
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬146. Systemic lupus erythematosus
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 147 | T cell receptor signaling pathway 💬 34 genes, 46 drugs (DrugBank) and 80 diseases  | 
TNF [1] TNF 💬T cell receptor signaling pathway
  | 
Etanercept  Etanercept  💬T cell receptor signaling pathway
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬147. T cell receptor signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 148 | Terpenoid backbone biosynthesis 💬 4 genes, 12 drugs (DrugBank) and 53 diseases  | 
HMGCR [1] HMGCR 💬Terpenoid backbone biosynthesis
  | 
Simvastatin  Simvastatin  💬Terpenoid backbone biosynthesis
  | Simvastatin | 006 [21]  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬148. Terpenoid backbone biosynthesis
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 149 | TGF-beta signaling pathway 💬 10 genes, 20 drugs (DrugBank) and 55 diseases  | 
ACVR2A [2] ACVR2A, ACVR2B 💬
 | 
Bimagrumab  Bimagrumab  💬TGF-beta signaling pathway
  | Bimagrumab | 015 [1] 15 💬149. TGF-beta signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 150 | TGF-beta signaling pathway 💬 10 genes, 20 drugs (DrugBank) and 55 diseases  | 
TNF [1] TNF 💬TGF-beta signaling pathway
  | 
Etanercept  Etanercept  💬TGF-beta signaling pathway
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬150. TGF-beta signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 151 | Th17 cell differentiation 💬 43 genes, 66 drugs (DrugBank) and 97 diseases  | 
IL1R1 [1] IL1R1 💬Th17 cell differentiation
  | 
Anakinra  Anakinra  💬Th17 cell differentiation
  | Anakinra | 002 [18]  2 , 13, 15, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬151. Th17 cell differentiation
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 152 | Th17 cell differentiation 💬 43 genes, 66 drugs (DrugBank) and 97 diseases  | 
MTOR [1] MTOR 💬Th17 cell differentiation
  | 
Sirolimus  Sirolimus  💬Th17 cell differentiation
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬152. Th17 cell differentiation
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 153 | Thermogenesis 💬 17 genes, 29 drugs (DrugBank) and 82 diseases  | 
MTOR [1] MTOR 💬Thermogenesis
  | 
Sirolimus  Sirolimus  💬Thermogenesis
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬153. Thermogenesis
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 154 | Thermogenesis 💬 17 genes, 29 drugs (DrugBank) and 82 diseases  | 
PPARG [1] PPARG 💬Thermogenesis
  | 
Pioglitazone  Pioglitazone  💬Thermogenesis
  | Pioglitazone | 002 [17]  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬154. Thermogenesis
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 155 | Thyroid cancer 💬 8 genes, 16 drugs (DrugBank) and 28 diseases  | 
PPARG [1] PPARG 💬Thyroid cancer
  | 
Pioglitazone  Pioglitazone  💬Thyroid cancer
  | Pioglitazone | 002 [17]  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬155. Thyroid cancer
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 156 | Thyroid hormone signaling pathway 💬 24 genes, 41 drugs (DrugBank) and 67 diseases  | 
MTOR [1] MTOR 💬Thyroid hormone signaling pathway
  | 
Sirolimus  Sirolimus  💬Thyroid hormone signaling pathway
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬156. Thyroid hormone signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 157 | TNF signaling pathway 💬 18 genes, 56 drugs (DrugBank) and 84 diseases  | 
LTA [2] LTA, TNF 💬
 | 
Etanercept  Etanercept  💬TNF signaling pathway
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬157. TNF signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 158 | Toll-like receptor signaling pathway 💬 36 genes, 46 drugs (DrugBank) and 65 diseases  | 
TNF [1] TNF 💬Toll-like receptor signaling pathway
  | 
Etanercept  Etanercept  💬Toll-like receptor signaling pathway
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬158. Toll-like receptor signaling pathway
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 159 | Toxoplasmosis 💬 25 genes, 39 drugs (DrugBank) and 64 diseases  | 
TNF [1] TNF 💬Toxoplasmosis
  | 
Etanercept  Etanercept  💬Toxoplasmosis
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬159. Toxoplasmosis
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 160 | Transcriptional misregulation in cancer 💬 26 genes, 49 drugs (DrugBank) and 76 diseases  | 
IL1R2 [1] IL1R2 💬Transcriptional misregulation in cancer
  | 
Anakinra  Anakinra  💬Transcriptional misregulation in cancer
  | Anakinra | 002 [18]  2 , 13, 15, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬160. Transcriptional misregulation in cancer
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 161 | Transcriptional misregulation in cancer 💬 26 genes, 49 drugs (DrugBank) and 76 diseases  | 
PPARG [1] PPARG 💬Transcriptional misregulation in cancer
  | 
Pioglitazone  Pioglitazone  💬Transcriptional misregulation in cancer
  | Pioglitazone | 002 [17]  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬161. Transcriptional misregulation in cancer
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 162 | Tuberculosis 💬 49 genes, 65 drugs (DrugBank) and 91 diseases  | 
TNF [1] TNF 💬Tuberculosis
  | 
Etanercept  Etanercept  💬Tuberculosis
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬162. Tuberculosis
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 163 | Type I diabetes mellitus 💬 11 genes, 22 drugs (DrugBank) and 68 diseases  | 
LTA [2] LTA, TNF 💬
 | 
Etanercept  Etanercept  💬Type I diabetes mellitus
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬163. Type I diabetes mellitus
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 164 | Type II diabetes mellitus 💬 14 genes, 39 drugs (DrugBank) and 91 diseases  | 
MTOR [1] MTOR 💬Type II diabetes mellitus
  | 
Sirolimus  Sirolimus  💬Type II diabetes mellitus
  | Sirolimus | 002 [40]  2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬164. Type II diabetes mellitus
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 165 | Type II diabetes mellitus 💬 14 genes, 39 drugs (DrugBank) and 91 diseases  | 
TNF [1] TNF 💬Type II diabetes mellitus
  | 
Etanercept  Etanercept  💬Type II diabetes mellitus
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬165. Type II diabetes mellitus
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 166 | Viral protein interaction with cytokine and cytokine receptor 💬 17 genes, 29 drugs (DrugBank) and 60 diseases  | 
LTA [2] LTA, TNF 💬
 | 
Etanercept  Etanercept  💬Viral protein interaction with cytokine and cytokine receptor
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬166. Viral protein interaction with cytokine and cytokine receptor
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 167 | Yersinia infection 💬 22 genes, 39 drugs (DrugBank) and 69 diseases  | 
ITGA4 [1] ITGA4 💬Yersinia infection
  | 
Natalizumab  Natalizumab  💬Yersinia infection
  | Natalizumab | 013 [6] 13, 15, 25, 46, 63, 96 💬167. Yersinia infection
  | 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 168 | Yersinia infection 💬 22 genes, 39 drugs (DrugBank) and 69 diseases  | 
TNF [1] TNF 💬Yersinia infection
  | 
Etanercept  Etanercept  💬Yersinia infection
  | Etanercept | 015 [16] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬168. Yersinia infection
  |